The metabolically healthy but obese individual presents a favorable inflammation profile.

By A. Karelis, May Faraj, J. Bastard, D. St-Pierre, M. Brochu, D. Prud'homme, R. Rabasa‐Lhoret. Journal of Clinical Endocrinology and Metabolism, 2005

600 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/90c44fd8fda606c0adc318b5e565376cccdee81d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. A. Chait
2. Laura J. den Hartigh

In Endocrinology, Diabetes and Metabolism

1. H. Kwon
2. J. Pessin
3. A. Chait
4. Laura J. den Hartigh

In Epidemiology

1. H. Kwon
2. J. Pessin
3. A. Chait
4. Laura J. den Hartigh

Citations in the corpus

• Are Metabolically Healthy Overweight and Obesity Benign Conditions? (2013, unknown): “8) 250 (32) Meigs et al, 2006 (8) 981 (33.”
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “Such individuals have been classified as having “metabolically healthy obesity” (MHO), and appear to be distinct from those with “metabolically unhealthy obesity” (MUHO) in that they remain insulin sensitive and do not have much adipose tissue inflammation or other features of the metabolic syndrome”
• Adipokines Mediate Inflammation and Insulin Resistance (2013, background): “Although the insulin resistant obese population displays adipose tissue inflammation, the metabolically benign obese population has a similar adipose tissue inflammatory cytokine, adipokine, and immune cell distribution as normal insulin sensitive non-obese individuals (Karelis et al., 2005).”